Search
Aeon Biopharma Inc
AEONAdd to Watchlist
0.723USD
+0.003+0.47%
Market hours （ET）Quotes delayed by 15 min
18.29MMarket Cap
LossP/E TTM
Aeon Biopharma Inc Earnings Date
Period
FY2026 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.29
92.66%
Analyst Rating
BUY
2026-06-30
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its current assets were 6.62M, with a year-on-year change of 94.97.
What are the total assets of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its total assets of Aeon Biopharma Inc were 8.63M, with a year-on-year change of 55.22.
What are the total liabilities of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its total liabilities of Aeon Biopharma Inc were 25.38M, with a year-on-year change of -58.11.
What is the total equity of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its total equity of Aeon Biopharma Inc was -16.75M, with a year-on-year change of 69.56.
What is the net financing of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its net financing of Aeon Biopharma Inc was 20.30M, with a year-on-year change of 34.05.
What is the Earnings Per Share (EPS) of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -0.29, with a year-on-year change of 92.66.
What is the debt-to-asset ratio of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its debt-to-asset ratio was 17.87, with a year-on-year change of -97.13.
What is the operating profit of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its operating profit was -5.93M, with a year-on-year change of 63.61.